BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 5
• 6
• 7
• 8
• 11
• 12
• 13
• 14
• 15
• 18
• 19
• 20
• 21
• 22
• 25
• 26
• 27
• 28
• 29

• Drug Development

  Merck & Co. Release: Results Of Pivotal TAILOR Study Confirm Addition Of Erbitux To FOLFOX Significantly Improves Outcomes In RAS Wild-Type Metastatic Colorectal Cancer

  July 1, 2016

   · 

  7 min read
• Business

  Celgene To Announce Second Quarter 2016 Results On July 28, 2016

  July 1, 2016

   · 

  1 min read
• Business

  Cannabis Science Inc. Guidance; Corporate Headquarters Relocated To California As It Negotiates For A Los Angeles, California Laboratory/Medical Treatment Center

  July 1, 2016

   · 

  6 min read
• Drug Development

  Allergan Receives Positive Opinion Through European Decentralised Procedure For BELKYRA (Deoxycholic Acid) For Patients With Submental Fullness

  July 1, 2016

   · 

  8 min read
• Drug Development

  NeuroDerm Announces Start Of U.S. Patient Enrollment In Trial 006, A Phase II Trial Of ND0612H For Advanced Parkinson’s Disease

  July 1, 2016

   · 

  6 min read
• Business

  Pacira to Pay Termination Fee of About $7.3 Million to CrossLink

  July 1, 2016

   · 

  1 min read
• Business

  Ligand Receives $4 Million From Expansion Of Two OmniAb License Agreements

  July 1, 2016

   · 

  5 min read
• AstraZeneca PLC Terminates Valeant’s Brodalumab Development Agreement for Europe

  July 1, 2016

   · 

  4 min read
• Drug Development

  Strekin AG Announces The Presentation Of Key STR001 Data At The Conference On Molecular Biology Of Hearing And Deafness, Cambridge UK

  July 1, 2016

   · 

  3 min read
• Deals

  Completion Of The Sale Of Canberra To Mirion Technologies

  July 1, 2016

   · 

  3 min read